SCHEMBL20090076

SCHEMBL20090076

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc3c(ccc4c5ccccc5c5nc6ccccc6n5c34)c2)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.38
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 5/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 5/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.34
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34
CSNK2A2 P19784 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960325 0.94 CYP11B1 (0.32) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL20090190 0.93 ALDH1A1 (0.33) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL20090084 0.93 HPGD (0.34) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL19960326 0.92 CYP11B1 (0.34) KMT2AMEN1CYP2C9CYP11B1CYP11B2
SCHEMBL20090222 0.91 HPGD (0.39) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL19960320 0.90 CYP11B1 (0.31) CYP11B1CYP11B2TUBB4ATUBBTUBA3C
SCHEMBL20090106 0.90 HPGD (0.34) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL19929009 0.89 HPGD (0.43) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL19960340 0.89 EGLN1 (0.31)
SCHEMBL19929007 0.88 HPGD (0.39) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 HPGD 2982/4885KDM4E 1997/4885ALDH1A1 750/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 HPGD 2982/4885KDM4E 1997/4885ALDH1A1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.